Our Exciting Journey to ACT-451840
We describe our work resulting in the selection of ACT-451840 ( 38 ) as a novel antimalarial drug with a novel mode of action. The compound was broadly characterized in vitro as well as in vivo in rat PK experiments as well as two different mouse malaria models. In the P. berghei infected mouse mode...
Saved in:
Main Authors: | Christoph Boss, Sergio Wittlin |
---|---|
Format: | article |
Language: | DE EN FR |
Published: |
Swiss Chemical Society
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/93b7c702dfa74ab3aef04287a807090c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fostering Research Synergies between Chemists in Swiss Academia and at Novartis
by: Arndt Meyer, et al.
Published: (2021) -
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
by: Annarita Del Gatto, et al.
Published: (2021) -
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
by: Simona Rapposelli, et al.
Published: (2021) -
Click Chemistry in Natural Product Modification
by: Xiang Zhang, et al.
Published: (2021) -
Challenges, Advances and Opportunities in Exploring Natural Products to Control Arboviral Disease Vectors
by: Daniel P. Demarque, et al.
Published: (2021)